• Carmen Riley appointed as new CEO/Executive Director
• Orderly transition from current CEO David Collins
• Carmen has deep understanding of Paragon's business and healthcare market

Paragon Care Limited (ASX: PGC), a leading healthcare wholesaler, distributor, and manufacturer in the Asia Pacific region, has announced the appointment of Carmen Riley as its new Chief Executive Officer and Executive Director, effective July 1, 2025. Carmen Riley has been the Chief Operating Officer and Executive Director of Paragon Care since the merger with Clifford Hallam Healthcare Pty Ltd (CH2), and prior to that, she held various senior roles at CH2 for 15 years. The appointment is part of an orderly transition from the current Chief Executive Officer and Managing Director, David Collins. David will stay on as Managing Director until June 30, 2026, at which point the expectation is that Carmen will then be appointed as Managing Director of Paragon Care. This has been Paragon's long-term plan, and with a material amount of the integration between Paragon, Oborne, and CH2 now complete, the company believes it is the right time for a new Chief Executive Officer to take control of the business and implement its next 5-year growth strategies.Carmen Riley has a deep understanding of the Paragon Care business and the healthcare market, with extensive experience managing both sales teams and the supply chain area. This change will ensure Paragon Care can have the best possibility to grow long term and create further equity for all shareholders. Over the next 12 months, David Collins will support Carmen through this transition, focusing on ensuring she can effectively manage the business, completing the final parts of the Paragon and CH2 integration, and working on the M&A pipeline.